TC Biopharm ()

0.01
-0.00 (-33.33%)
At close: Jan 28, 2025, 11:38 AM

Balance Sheet (Annual)

Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
Year FY23 FY22 FY21 FY20 FY19
Cash & Equivalents 2.46M 4.81M 1.57M 748.01K 956.50K
Short-Term Investments n/a n/a n/a n/a n/a
Long-Term Investments n/a n/a n/a n/a n/a
Other Long-Term Assets n/a n/a -1 n/a n/a
Receivables n/a n/a n/a n/a 107.75K
Inventory n/a n/a n/a n/a n/a
Other Current Assets 4.07M 836.14K 811.30K 230.72K 242.41K
Total Current Assets 5.70M 7.45M 3.86M 2.22M 4.22M
Property-Plant & Equipment 2.62M 3.29M 3.68M 4.63M 5.61M
Goodwill & Intangibles 615.17K 553.02K 483.58K 423.84K 305.63K
Total Long-Term Assets 3.23M 3.84M 4.17M 5.05M 5.92M
Total Assets 8.93M 11.29M 8.02M 7.27M 10.14M
Account Payables 1.85M 882.36K 1.42M 638.37K 627.93K
Deferred Revenue n/a n/a n/a n/a n/a
Short-Term Debt 305.32K 981.52K 7.57M 442.70K 414.63K
Other Current Liabilities 2.46M 7.30M 9.61M 3.11M 2.84M
Total Current Liabilities 4.75M 9.16M 20.58M 4.19M 3.88M
Long-Term Debt 2.99M 1.80M 2.14M 2.58M 3.02M
Other Long-Term Liabilities -1.50M n/a n/a n/a n/a
Total Long-Term Liabilities 1.50M 1.80M 4.00M 6.43M 8.79M
Total Liabilities 6.25M 10.96M 24.58M 10.61M 12.68M
Total Debt 1.80M 2.45M 15.87M 2.58M 3.02M
Common Stock 2.06K 397.49K 195.48K 194.58K 1.78M
Retained Earnings -38.84M -33.37M -33.47M -19.89M -15.42M
Comprehensive Income n/a n/a 16.71M 16.35M n/a
Shareholders Equity 2.69M 331.26K -16.56M -3.35M -2.54M
Total Investments n/a n/a n/a n/a n/a